Cost-effectiveness of varenicline for smoking cessation in the Netherlands

M. Hoogendoorn, M. Rutten-van Mölken (Rotterdam, Netherlands)

Source: Annual Congress 2007 - Ethical and economic choices in respiratory care
Session: Ethical and economic choices in respiratory care
Session type: Oral Presentation
Number: 1583
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hoogendoorn, M. Rutten-van Mölken (Rotterdam, Netherlands). Cost-effectiveness of varenicline for smoking cessation in the Netherlands. Eur Respir J 2007; 30: Suppl. 51, 1583

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Cost-effectiveness of 5 smoking cessation interventions
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Costs and benefits accruing from smoking cessation with varenicline
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009

Efficacy of bupropion therapy in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 153s
Year: 2004

Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015



Effectiveness and cost-effectiveness of smoking cessation interventions
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



The impact and costs of reimbursed smoking cessation using varenicline in Denmark
Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine
Year: 2010



Medical treatment effectiveness in smoking cessation
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017

The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008

Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004

Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


Efficacy of bupropion SR in a smoking cessation programme for heavy smokers: preliminary results
Source: Eur Respir J 2001; 18: Suppl. 33, 167s
Year: 2001

Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015

Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


e-cigarettes for smoking cessation
Source: International Congress 2015 – E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing?
Year: 2015